Jazz Pharmaceuticals plc 4

Mark Douglas Smith, an insider at Jazz Pharmaceuticals plc, sold 1,157 ordinary shares at about $230.55 per share under a Rule 10b5-1 plan.

On June 15, 2026, insider Mark Douglas Smith of Jazz Pharmaceuticals plc executed an automatic sale of 1,157 ordinary shares at an average price of approximately $230.55 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 9, 2026. The transaction, which totaled roughly $267,000 in value, was classified as a discretionary account transaction with direct ownership and reduced his holdings to 9,680 ordinary shares following the sale. The filing notes that the trade occurred automatically under the plan and was not a discretionary decision by the reporting person at the time of execution.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

sec

Accession

0001756253-26-000004

Alert Tier

6